查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1181069

全球深部脑刺激 (DBS) 设备市场：市场规模、份额、趋势分析、机会和按类型、分销渠道、最终用户、功能、应用和地区分类的预测 2018-2028

Deep Brain Stimulation Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018-2028, Segmented By Type ; Distribution Channel ; End User ; Functionality ; Application ; Region
出版日期: | 出版商: Blueweave Consulting | 英文 245 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球深部脑刺激 (DBS) 设备市场收入将在 2021 年达到 11 亿美元，到 2028 年底将达到近 20 亿美元，在 2022-2028 年的预测期内復合年增长率为 9.2%。预计生长。 由于老年人口增加和技术进步，预计该市场将以高复合年增长率增长。

由于与帕金森病 (PD)、肌张力障碍和多发性硬化症相关的不自主运动的患者数量不断增加，市场正在蓬勃发展。 此外，对微创手术的需求增加以及患者预后的改善是市场的主要驱动力。

本报告研究了全球深部脑刺激 (DBS) 设备市场，提供了对市场变量、按类型、分销渠道、最终用户、功能和应用、竞争格局、公司概况等进行的市场分析。

内容

第一章研究框架

第 2 章执行摘要

第 3 章全球深部脑刺激 (DBS) 设备市场变量洞察

  • 行业价值链分析
  • DROC 分析
    • 增长动力
      • 全球神经系统疾病患病率上升
      • 增加研发 (R&D)
      • 发达国家对微创手术的需求增加
    • 约束因素
      • 深部脑刺激 (DBS) 疗法的高昂费用
    • 机会
      • 疗效更高，患者接受度更高
    • 任务
      • IPG 风险会影响深部脑刺激 (DBS) 设备的接受度
  • 技术进步/最新发展
  • 监管框架
  • 波特的五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争激烈程度

第 4 章。全球深部脑刺激 (DBS) 设备市场概况

  • 市场规模和预测：按价值（2020-2028 年）
    • 按金额（百万美元）
  • 市场份额/预测
    • 按类型
      • 开环 DBS
      • 闭环 DBS
    • 按分销渠道
      • 在线
      • 离线
    • 最终用户
      • 医院
      • 专门的神经病学诊所
      • 研究中心
      • 其他
    • 职能性别
      • 单侧双通道深部脑刺激 (DBS) 设备
      • 双侧脑深部刺激 (DBS) 装置
    • 通过使用
      • 帕金森病
      • 癫痫症
      • 特发性震颤
      • 肌张力障碍
      • 强迫症 (OCD)
      • 其他
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和非洲

第 5 章北美深部脑刺激 (DBS) 设备市场

  • 市场规模/预测：按金额（2018-2028 年）
    • 按金额（百万美元）
  • 市场份额/预测
    • 按类型
    • 按分销渠道
    • 最终用户
    • 职能性别
    • 通过使用
    • 按国家
      • 美国
      • 加拿大

第 6 章：欧洲深部脑刺激 (DBS) 设备市场

  • 市场规模/预测：按金额（2018-2028 年）
    • 按金额（百万美元）
  • 市场份额/预测
    • 按类型
    • 按分销渠道
    • 最终用户
    • 职能性别
    • 通过使用
    • 按国家
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 荷兰
      • 比利时
      • 北欧国家
      • 其他欧洲

第 7 章亚太地区深部脑刺激 (DBS) 设备市场

  • 市场规模/预测：按金额（2018-2028 年）
    • 按金额（百万美元）
  • 市场份额/预测
    • 按类型
    • 按分销渠道
    • 最终用户
    • 职能性别
    • 通过使用
    • 按国家
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚
      • 印度尼西亚
      • 马来西亚
      • 菲律宾
      • 新加坡
      • 亚太其他地区

第 8 章拉丁美洲深部脑刺激 (DBS) 设备市场

  • 市场规模/预测：按金额（2018-2028 年）
    • 按金额（百万美元）
  • 市场份额/预测
    • 按类型
    • 按分销渠道
    • 最终用户
    • 职能性别
    • 通过使用
    • 按国家
      • 巴西
      • 墨西哥
      • 阿根廷
      • 智利
      • 秘鲁
      • 其他拉丁美洲

第 9 章：中东和非洲的深部脑刺激 (DBS) 设备市场

  • 市场规模/预测：按金额（2018-2028 年）
    • 按金额（百万美元）
  • 市场份额/预测
    • 按类型
    • 按分销渠道
    • 最终用户
    • 职能性别
    • 通过使用
    • 按国家
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 南非
      • 卡塔尔
      • 土耳其
      • 尼日利亚
      • 埃及
      • 阿尔及利亚
      • 肯尼亚
      • 摩洛哥
      • 其他中东和非洲地区

第10章竞争格局

  • 主要公司及其产品列表
  • 2021 年市场份额分析
  • 竞争基准：按操作参数
  • 重大战略发展（合併、收购、合作等）

第 11 章 COVID-19 对全球深部脑刺激 (DBS) 设备市场的影响

第12章公司简介

  • Abbott
  • Aleva Neurotherapeutics
  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic
  • NeuroSigma, Inc.
  • NeuroPace, Inc.
  • Nexstim

第 13 章关键战略建议

第 14 章研究方法论

简介目录
Product Code: BWC22604

Global Deep Brain Stimulation Devices Market to Reach USD 2.0 Billion by 2028

Global deep brain stimulation devices market is forecasted to grow at a higher CAGR due to the rise in geriatric population and technological advancements. The rapid relief from symptoms provided by deep brain stimulation makes it the treatment of choice as it reduces the dose and frequency of drugs consumed on a daily basis via the oral route, leading to rise in patient satisfaction and trust in the medical intervention.

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global deep brain stimulation was worth USD 1.1 billion in the year 2021. The market is projected to grow at a CAGR of 9.2% from 2022-2028 (forecast period), earning revenues of around USD 2.0 billion by the end of 2028. The market is booming owing to the rise in individuals with Parkinson's disease (PD), dystonia, and multiple sclerosis-related involuntary movements. Additionally, the increased demand for minimally invasive procedures as a result of better patient outcomes is a significant market driver. Furthermore, the deep brain stimulation device market is supported by the advent of telehealth consultations and e-health apps to frequently monitor PD patients during the COVID-19 pandemic.

Higher Efficacy, Greater Patient Acceptance Boosting the Global Deep Brain Stimulation Market

Due to the increasingly aging population, altered lifestyles, rising rates of obesity, and high blood pressure, among other things, there are now significantly more neurological illnesses, such as Parkinson's disease. Over 50 million individuals have epilepsy, according to a World Health Organization (WHO) report released in September 2021. Alzheimer's disease is responsible for between 60 and 70% of dementia cases. An estimated 35.6 million people are afflicted with dementia, and 7.7 million new cases are identified each year.

Additionally, the market for deep brain stimulation devices is expected to expand substantially over the course of the forecast period as a result of the rise in patients with these conditions and the rising usage of these devices, which facilitate recovery. For instance, deep brain stimulation devices were reportedly utilized on over 160,000 patients globally in 2019 for a variety of neurological and non-neurological diseases, with the number rising year after year, according to the National Center for Biotechnology Information (NCBI).

Restraint

Risk of IPG (Implantable Pulse Generator Associated Infection) Affects Acceptance of Deep Brain Stimulation Devices

Throughout the assessment period, the global market for deep brain stimulation devices is anticipated to grow at a positive year-on-year rate. However, there are a few variables that are predicted to work against the market's growth. The hazards associated with deep brain stimulation device operations are one of the major reasons impeding the market's growth.

For example, in deep brain systems, the implanted pulse generator (IPG) is the main power source and programmable element. However, the danger of infection from IPG is significant enough and is predicted to limit the use of deep brain stimulation devices for Parkinson's disease and other neurological conditions. As a result, healthcare organizations should raise knowledge regarding antibiotic impregnation and co-administration, as well as other surgical considerations during IPG implantation, such as using tack-up sutures and smaller profile devices.

Global Deep Brain Stimulation Devices market - By Functionality

Dual-channel deep brain stimulators and single-channel deep brain stimulators are the two product categories that make up the market. Throughout the forecast period, the dual channel deep brain stimulator segment is anticipated to maintain a significant share. This might be a result of deep brain stimulator technology continuing to progress. Deep brain stimulators with dual channels have more sophisticated technology than those with single channels. One-sided dual-channel deep brain stimulators, which deliver electrical pulse stimulation through two DEEP BRAIN STIMULATION leads, were created to simplify the procedure for bilateral treatment and increase patient comfort. So, over the projection period, growing developments in DEEP BRAIN STIMULATION stimulators will significantly boost the market growth.

Global Deep Brain Stimulation Devices Market - By Application

Based on application, the market has been further divided into Parkinson's disease, epilepsy, essential tremor, dystonia, and obsessive-compulsive disorder. The Parkinson's disease segment dominated the market for deep brain stimulation devices in 2021, accounting for over 60% of the revenue share owing to the high prevalence of Parkinson's disease worldwide. The Parkinson's Foundation estimates that 60,000 Americans are given a Parkinson's disease diagnosis each year. This is expected to encourage segment expansion during the next years.

Regional Insights

The global deep brain stimulation devices market is currently dominated by North America in terms of revenue. According to a National Institute of Neurological Disorders and Stroke (NINDS) report, North America dominated the market due to the presence of cutting-edge and innovative healthcare infrastructure in this region, the high prevalence of neurological disorders like Parkinson's disease and epilepsy, and government initiatives that favor patients with neurological conditions. Moreover, significant market expansion potentially occurs in the Asia Pacific region. Increasing research in the neurological area, an increase in patients with neurodegenerative diseases, and enhanced clinical procedures are all driving this region's market growth. However, there is evidence of rapid growth in Asian countries like Japan and South Korea, which can foster market expansion due to the rise in patients and the emergence of institutions focused on neurological research, among other things.

Impact of COVID-19 on Global Deep Brain Stimulation Market

The unprecedented global public health emergency known as COVID-19 has had an impact on almost every business, and the long-term effects are anticipated to have an impact on industry growth throughout the course of the projected period. It is important to understand that the deep brain stimulation devices market has been negatively impacted as a result of the global restrictions brought on by the pandemic in order to ensure the inclusion of underlying COVID-19 concerns and potential future directions. With prohibitions lifted in most countries and a larger proportion of the population immunized, it is predicted that the deep brain stimulation devices market will experience positive growth during the forecast period.

Competitive Landscape

The leading companies in the market include Abbott, Aleva Neurotherapeutics, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroSigma, Inc., NeuroPace, Inc., Nexstim, and Other Prominent Players. Major market competitors use various techniques, including mergers and acquisitions, innovative therapies, and others, to stay competitive and gain an advantage over rivals.

The global deep brain stimulation devices market is consolidated with the presence of several manufacturing companies globally. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global deep brain stimulation market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global deep brain stimulation devices market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Deep Brain Stimulation Devices Market Variable Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Global Rise in Prevalence of Neurological Disorders
      • 3.2.1.2. Rising Research & Development (R&D)
      • 3.2.1.3. Increasing Demand for Minimally Invasive Surgery in Developed Countries
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Deep Brain Stimulation Therapy
    • 3.2.3. Opportunities
      • 3.2.3.1. Higher Efficacy, Greater Patient Acceptance
    • 3.2.4. Challenges
      • 3.2.4.1. Risk of IPG (Implantable Pulse Generator Associated Infection) Affects Acceptance of Deep Brain Stimulation Devices
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Deep Brain Stimulation Devices Market Overview

  • 4.1. Market Size & Forecast by Value, 2020-2028
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Open Loop DBS
      • 4.2.1.2. Closed Loop DBS
    • 4.2.2. By Distributional Channel
      • 4.2.2.1. Online
      • 4.2.2.2. Offline
    • 4.2.3. By End User
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Specialized Neurology Clinics
      • 4.2.3.3. Research Centers
      • 4.2.3.4. Others
    • 4.2.4. By Functionality
      • 4.2.4.1. One-sided dual channel deep brain stimulator
      • 4.2.4.2. Two-sided deep brain stimulators
    • 4.2.5. By Application
      • 4.2.5.1. Parkinson's Disease
      • 4.2.5.2. Epilepsy
      • 4.2.5.3. Essential Tremor
      • 4.2.5.4. Dystonia
      • 4.2.5.5. Obsessive Compulsive Disorder (OCD)
      • 4.2.5.6. Others
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia Pacific
      • 4.2.6.4. Latin America
      • 4.2.6.5. Middle East and Africa

5. North America Deep Brain Stimulation Devices Market

  • 5.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Distribution Channel
    • 5.2.3. By End User
    • 5.2.4. By Functionality
    • 5.2.5. By Application
    • 5.2.6. By Country
      • 5.2.6.1. United States
      • 5.2.6.1.1. By Type
      • 5.2.6.1.2. By Distribution Channel
      • 5.2.6.1.3. By End User
      • 5.2.6.1.4. By Functionality
      • 5.2.6.1.5. By Application
      • 5.2.6.2. Canada
      • 5.2.6.2.1. By Type
      • 5.2.6.2.2. By Distribution Channel
      • 5.2.6.2.3. By End User
      • 5.2.6.2.4. By Functionality
      • 5.2.6.2.5. By Application

6. Europe Deep Brain Stimulation Devices Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By End User
    • 6.2.4. By Functionality
    • 6.2.5. By Application
    • 6.2.6. By Country
      • 6.2.6.1. Germany
      • 6.2.6.1.1. By Type
      • 6.2.6.1.2. By Distribution Channel
      • 6.2.6.1.3. By End User
      • 6.2.6.1.4. By Functionality
      • 6.2.6.1.5. By Application
      • 6.2.6.2. United Kingdom
      • 6.2.6.2.1. By Type
      • 6.2.6.2.2. By Distribution Channel
      • 6.2.6.2.3. By End User
      • 6.2.6.2.4. By Functionality
      • 6.2.6.2.5. By Application
      • 6.2.6.3. Italy
      • 6.2.6.3.1. By Type
      • 6.2.6.3.2. By Distribution Channel
      • 6.2.6.3.3. By End User
      • 6.2.6.3.4. By Functionality
      • 6.2.6.3.5. By Application
      • 6.2.6.4. France
      • 6.2.6.4.1. By Type
      • 6.2.6.4.2. By Distribution Channel
      • 6.2.6.4.3. By End User
      • 6.2.6.4.4. By Functionality
      • 6.2.6.4.5. By Application
      • 6.2.6.5. Spain
      • 6.2.6.5.1. By Type
      • 6.2.6.5.2. By Distribution Channel
      • 6.2.6.5.3. By End User
      • 6.2.6.5.4. By Functionality
      • 6.2.6.5.5. By Application
      • 6.2.6.6. The Netherlands
      • 6.2.6.6.1. By Type
      • 6.2.6.6.2. By Distribution Channel
      • 6.2.6.6.3. By End User
      • 6.2.6.6.4. By Functionality
      • 6.2.6.6.5. By Application
      • 6.2.6.7. Belgium
      • 6.2.6.7.1. By Type
      • 6.2.6.7.2. By Distribution Channel
      • 6.2.6.7.3. By End User
      • 6.2.6.7.4. By Functionality
      • 6.2.6.7.5. By Application
      • 6.2.6.8. NORDIC Countries
      • 6.2.6.8.1. By Type
      • 6.2.6.8.2. By Distribution Channel
      • 6.2.6.8.3. By End User
      • 6.2.6.8.4. By Functionality
      • 6.2.6.8.5. By Application
      • 6.2.6.9. Rest of Europe
      • 6.2.6.9.1. By Type
      • 6.2.6.9.2. By Distribution Channel
      • 6.2.6.9.3. By End User
      • 6.2.6.9.4. By Functionality
      • 6.2.6.9.5. By Application

7. Asia Pacific Deep Brain Stimulation Devices Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By End User
    • 7.2.4. By Functionality
    • 7.2.5. By Application
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Type
      • 7.2.6.1.2. By Distribution Channel
      • 7.2.6.1.3. By End User
      • 7.2.6.1.4. By Functionality
      • 7.2.6.1.5. By Application
      • 7.2.6.2. India
      • 7.2.6.2.1. By Type
      • 7.2.6.2.2. By Distribution Channel
      • 7.2.6.2.3. By End User
      • 7.2.6.2.4. By Functionality
      • 7.2.6.2.5. By Application
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Type
      • 7.2.6.3.2. By Distribution Channel
      • 7.2.6.3.3. By End User
      • 7.2.6.3.4. By Functionality
      • 7.2.6.3.5. By Application
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Type
      • 7.2.6.4.2. By Distribution Channel
      • 7.2.6.4.3. By End User
      • 7.2.6.4.4. By Functionality
      • 7.2.6.4.5. By Application
      • 7.2.6.5. Australia
      • 7.2.6.5.1. By Type
      • 7.2.6.5.2. By Distribution Channel
      • 7.2.6.5.3. By End User
      • 7.2.6.5.4. By Functionality
      • 7.2.6.5.5. By Application
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Type
      • 7.2.6.6.2. By Distribution Channel
      • 7.2.6.6.3. By End User
      • 7.2.6.6.4. By Functionality
      • 7.2.6.6.5. By Application
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Type
      • 7.2.6.7.2. By Distribution Channel
      • 7.2.6.7.3. By End User
      • 7.2.6.7.4. By Functionality
      • 7.2.6.7.5. By Application
      • 7.2.6.8. Philippines
      • 7.2.6.8.1. By Type
      • 7.2.6.8.2. By Distribution Channel
      • 7.2.6.8.3. By End User
      • 7.2.6.8.4. By Functionality
      • 7.2.6.8.5. By Application
      • 7.2.6.9. Singapore
      • 7.2.6.9.1. By Type
      • 7.2.6.9.2. By Distribution Channel
      • 7.2.6.9.3. By End User
      • 7.2.6.9.4. By Functionality
      • 7.2.6.9.5. By Application
      • 7.2.6.10. Rest of Asia Pacific
      • 7.2.6.10.1. By Type
      • 7.2.6.10.2. By Distribution Channel
      • 7.2.6.10.3. By End User
      • 7.2.6.10.4. By Functionality
      • 7.2.6.10.5. By Application

8. Latin America Deep Brain Stimulation Devices Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By End User
    • 8.2.4. By Functionality
    • 8.2.5. By Application
    • 8.2.6. By Country
      • 8.2.6.1. Brazil
      • 8.2.6.1.1. By Type
      • 8.2.6.1.2. By Distribution Channel
      • 8.2.6.1.3. By End User
      • 8.2.6.1.4. By Functionality
      • 8.2.6.1.5. By Application
      • 8.2.6.2. Mexico
      • 8.2.6.2.1. By Type
      • 8.2.6.2.2. By Distribution Channel
      • 8.2.6.2.3. By End User
      • 8.2.6.2.4. By Functionality
      • 8.2.6.2.5. By Application
      • 8.2.6.3. Argentina
      • 8.2.6.3.1. By Type
      • 8.2.6.3.2. By Distribution Channel
      • 8.2.6.3.3. By End User
      • 8.2.6.3.4. By Functionality
      • 8.2.6.3.5. By Application
      • 8.2.6.4. Chile
      • 8.2.6.4.1. By Type
      • 8.2.6.4.2. By Distribution Channel
      • 8.2.6.4.3. By End User
      • 8.2.6.4.4. By Functionality
      • 8.2.6.4.5. By Application
      • 8.2.6.5. Peru
      • 8.2.6.5.1. By Type
      • 8.2.6.5.2. By Distribution Channel
      • 8.2.6.5.3. By End User
      • 8.2.6.5.4. By Functionality
      • 8.2.6.5.5. By Application
      • 8.2.6.6. Rest of Latin America

9. Middle East and Africa Deep Brain Stimulation Devices Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By End User
    • 9.2.4. By Functionality
    • 9.2.5. By Application
    • 9.2.6. By Country
      • 9.2.6.1. Saudi Arabia
      • 9.2.6.1.1. By Type
      • 9.2.6.1.2. By Distribution Channel
      • 9.2.6.1.3. By End User
      • 9.2.6.1.4. By Functionality
      • 9.2.6.1.5. By Application
      • 9.2.6.2. UAE
      • 9.2.6.2.1. By Type
      • 9.2.6.2.2. By Distribution Channel
      • 9.2.6.2.3. By End User
      • 9.2.6.2.4. By Functionality
      • 9.2.6.2.5. By Application
      • 9.2.6.3. South Africa
      • 9.2.6.3.1. By Type
      • 9.2.6.3.2. By Distribution Channel
      • 9.2.6.3.3. By End User
      • 9.2.6.3.4. By Functionality
      • 9.2.6.3.5. By Application
      • 9.2.6.4. Qatar
      • 9.2.6.4.1. By Type
      • 9.2.6.4.2. By Distribution Channel
      • 9.2.6.4.3. By End User
      • 9.2.6.4.4. By Functionality
      • 9.2.6.4.5. By Application
      • 9.2.6.5. Turkey
      • 9.2.6.5.1. By Type
      • 9.2.6.5.2. By Distribution Channel
      • 9.2.6.5.3. By End User
      • 9.2.6.5.4. By Functionality
      • 9.2.6.5.5. By Application
      • 9.2.6.6. Nigeria
      • 9.2.6.6.1. By Type
      • 9.2.6.6.2. By Distribution Channel
      • 9.2.6.6.3. By End User
      • 9.2.6.6.4. By Functionality
      • 9.2.6.6.5. By Application
      • 9.2.6.7. Egypt
      • 9.2.6.7.1. By Type
      • 9.2.6.7.2. By Distribution Channel
      • 9.2.6.7.3. By End User
      • 9.2.6.7.4. By Functionality
      • 9.2.6.7.5. By Application
      • 9.2.6.8. Algeria
      • 9.2.6.8.1. By Type
      • 9.2.6.8.2. By Distribution Channel
      • 9.2.6.8.3. By End User
      • 9.2.6.8.4. By Functionality
      • 9.2.6.8.5. By Application
      • 9.2.6.9. Kenya
      • 9.2.6.9.1. By Type
      • 9.2.6.9.2. By Distribution Channel
      • 9.2.6.9.3. By End User
      • 9.2.6.9.4. By Functionality
      • 9.2.6.9.5. By Application
      • 9.2.6.10. Morocco
      • 9.2.6.10.1. By Type
      • 9.2.6.10.2. By Distribution Channel
      • 9.2.6.10.3. By End User
      • 9.2.6.10.4. By Functionality
      • 9.2.6.10.5. By Application
      • 9.2.6.11. Rest of Middle East and Africa
      • 9.2.6.11.1. By Type
      • 9.2.6.11.2. By Distribution Channel
      • 9.2.6.11.3. By End User
      • 9.2.6.11.4. By Functionality
      • 9.2.6.11.5. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their offerings
  • 10.2. Market Share Analysis, 2021
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Deep Brain Stimulation Devices Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, SWOT, and Strategic Outlook) **

  • 13.1. Abbott
  • 13.2. Aleva Neurotherapeutics
  • 13.3. Boston Scientific Corporation
  • 13.4. LivaNova PLC
  • 13.5. Medtronic
  • 13.6. NeuroSigma, Inc.
  • 13.7. NeuroPace, Inc.
  • 13.8. Nexstim
  • 13.9. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research

Primary & Secondary Research

  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations